These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35223501)

  • 1. Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients.
    Kgokolo MCM; Anderson K; Siwele SC; Steel HC; Kwofie LLI; Sathekge MM; Meyer PWA; Rapoport BL; Anderson R
    Front Oncol; 2022; 12():819790. PubMed ID: 35223501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3.
    Rapoport BL; Steel HC; Benn CA; Nayler S; Smit T; Heyman L; Theron AJ; Hlatshwayo N; Kwofie LLI; Meyer PWA; Anderson R
    Front Oncol; 2023; 13():1097309. PubMed ID: 37064132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma.
    Malinga NZ; Siwele SC; Steel HC; Kwofie LLI; Meyer PWA; Smit T; Anderson R; Rapoport BL; Kgokolo MCM
    Transl Oncol; 2022 May; 19():101384. PubMed ID: 35255355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
    Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
    Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic and Predictive Role of Xeroderma Pigmentosum Gene Expression in Melanoma.
    Fischer S; Hamed M; Emmert S; Wolkenhauer O; Fuellen G; Thiem A
    Front Oncol; 2022; 12():810058. PubMed ID: 35174087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy.
    Mariani E; Facchini A; Honorati MC; Lalli E; Berardesca E; Ghetti P; Marinoni S; Nuzzo F; Astaldi Ricotti GC; Stefanini M
    Clin Exp Immunol; 1992 Jun; 88(3):376-82. PubMed ID: 1535035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.
    Suzuki H; Kalair W; Shivji GM; Wang B; Toto P; Amerio P; Kraemer KH; Sauder DN
    J Invest Dermatol; 2001 Nov; 117(5):1151-5. PubMed ID: 11710926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.
    Rapoport BL; Steel HC; Hlatshwayo N; Theron AJ; Meyer PWA; Nayler S; Benn CA; Smit T; Kwofie LLI; Heyman L; Anderson R
    Front Immunol; 2022; 13():823842. PubMed ID: 35677046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.
    Gaspari AA; Fleisher TA; Kraemer KH
    J Clin Invest; 1993 Sep; 92(3):1135-42. PubMed ID: 7690772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D levels of XP-patients under stringent sun-protection.
    Hoesl M; Dietz K; Röcken M; Berneburg M
    Eur J Dermatol; 2010; 20(4):457-60. PubMed ID: 20494856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.
    Szarka A; Rigó J; Lázár L; Beko G; Molvarec A
    BMC Immunol; 2010 Dec; 11():59. PubMed ID: 21126355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy.
    Labuschagne Naidoo RB; Steel HC; Theron AJ; Anderson R; Tintinger GR; Rossouw TM
    Pathogens; 2024 Jun; 13(7):. PubMed ID: 39057767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of oxidative stress in xeroderma pigmentosum.
    Hayashi M
    Adv Exp Med Biol; 2008; 637():120-7. PubMed ID: 19181117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shining a light on xeroderma pigmentosum.
    DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.